NO20010627D0 - Anvendelse av Gingko Biloba ekstrakter for fremstilling av et medikament for behandling av amyotrofisk lateral sclerose - Google Patents
Anvendelse av Gingko Biloba ekstrakter for fremstilling av et medikament for behandling av amyotrofisk lateral scleroseInfo
- Publication number
- NO20010627D0 NO20010627D0 NO20010627A NO20010627A NO20010627D0 NO 20010627 D0 NO20010627 D0 NO 20010627D0 NO 20010627 A NO20010627 A NO 20010627A NO 20010627 A NO20010627 A NO 20010627A NO 20010627 D0 NO20010627 D0 NO 20010627D0
- Authority
- NO
- Norway
- Prior art keywords
- lateral sclerosis
- amyotrophic lateral
- drug
- preparation
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Psychiatry (AREA)
- Physical Education & Sports Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9810187A FR2782008B1 (fr) | 1998-08-07 | 1998-08-07 | Utilisation d'extraits de ginkgo biloba pour preparer un medicament destine a traiter la sclerose laterale amyotrophique |
PCT/FR1999/001948 WO2000007592A1 (fr) | 1998-08-07 | 1999-08-06 | Utilisation d'extraits de ginkgo biloba pour preparer un medicament destine a traiter la sclerose laterale amyotrophique |
Publications (3)
Publication Number | Publication Date |
---|---|
NO20010627L NO20010627L (no) | 2001-02-06 |
NO20010627D0 true NO20010627D0 (no) | 2001-02-06 |
NO327733B1 NO327733B1 (no) | 2009-09-14 |
Family
ID=9529516
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20010627A NO327733B1 (no) | 1998-08-07 | 2001-02-06 | Anvendelse av Gingko biloba-ekstrakter for fremstilling av et medikament for behandling av amyotrofisk lateral sklerose |
Country Status (12)
Country | Link |
---|---|
US (1) | US6524629B1 (no) |
EP (1) | EP1102586B1 (no) |
JP (1) | JP4510289B2 (no) |
AT (1) | ATE281162T1 (no) |
AU (1) | AU5170499A (no) |
CA (1) | CA2340021C (no) |
DE (1) | DE69921662T2 (no) |
ES (1) | ES2230873T3 (no) |
FR (1) | FR2782008B1 (no) |
NO (1) | NO327733B1 (no) |
PT (1) | PT1102586E (no) |
WO (1) | WO2000007592A1 (no) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2785808B1 (fr) * | 1998-11-13 | 2002-12-06 | Aventis Laboratoire | Association riluzole et alpha-tocopherol |
FR2827518B1 (fr) * | 2001-07-17 | 2005-07-08 | Sod Conseils Rech Applic | Utilisation d'extraits de ginkgo biloba pour preparer un medicament destine a traiter la sarcopenie |
JP4528490B2 (ja) * | 2002-06-25 | 2010-08-18 | 和光化学株式会社 | ギンコライド−aを含有する抗不安剤 |
WO2004074024A2 (en) | 2003-02-19 | 2004-09-02 | Pilkington North America, Inc. | Powered slider drive interface and drive assembly |
RU2005137567A (ru) * | 2003-05-02 | 2006-04-27 | Джорджтаун Юниверсити (Us) | Экстракт гинкго билоба как средство для лечения терапевтически индуцированной нейротоксичности |
WO2006004386A1 (es) * | 2004-07-02 | 2006-01-12 | Rojas Castaneda Patricia | Uso de un extracto del ginkgo biloba para preparar una medicina para tratar la enfermedad de parkinson |
AU2006299406A1 (en) * | 2005-09-30 | 2007-04-12 | Kinemed, Inc. | Microtubule synthesis as a biomarker |
CA2636333A1 (en) * | 2006-01-05 | 2007-07-19 | Kinemed, Inc. | Compositions and methods of treatment using modulators of motonueron diseases |
FR2904222A1 (fr) | 2006-07-27 | 2008-02-01 | Sod Conseils Rech Applic | Utilisation d4extraits de ginkgo biloba pour le traitement de maladies mitochondriales |
WO2009143365A2 (en) * | 2008-05-21 | 2009-11-26 | Kinemed, Inc. | Compositions and methods of treatment using modulators of motoneuron diseases |
GB0922064D0 (en) | 2009-12-17 | 2010-02-03 | Pilkington Group Ltd | Soda lime silica glass composition |
EP2804598B1 (en) * | 2012-01-17 | 2019-05-15 | Kyoto University | Prophylactic and therapeutic drug for amyotrophic lateral sclerosis and method of screening therefor |
WO2016114655A1 (en) * | 2015-01-12 | 2016-07-21 | Ry Pharma B.V. | Treating neuromuscular or neurologic disease through reducing gabaergic and/or glycinergic inhibitory neurotransmitter overstimulation |
WO2017065602A1 (en) * | 2015-10-13 | 2017-04-20 | Ry Pharma B.V. | Treating neuromuscular or neurologic disease through reducing gabaergic and/or glycinergic inhibitory neurotransmitter overstimulation |
CN108096243B (zh) * | 2017-11-24 | 2020-05-29 | 江苏康缘药业股份有限公司 | 银杏内酯组合物的医药用途 |
CN110893183A (zh) * | 2018-09-13 | 2020-03-20 | 成都百裕制药股份有限公司 | 银杏萜内酯在制备预防、缓解或治疗肌萎缩侧索硬化药物中的应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3338995A1 (de) * | 1983-10-27 | 1985-05-09 | Dr. Willmar Schwabe GmbH & Co, 7500 Karlsruhe | Bilobalid enthaltende arzneimittel |
DE3940094A1 (de) * | 1989-12-04 | 1991-06-06 | Montana Ltd | Wirkstoffkonzentrate und neue wirkstoff-kombinationen aus blaettern von ginkgo biloba, ein verfahren zu ihrer herstellung und die wirkstoff-konzentrate bzw. die wirkstoff-kombinationen enthaltenden arzneimittel |
DE4328374A1 (de) * | 1993-08-24 | 1995-03-02 | Deinlein Kalb Hans | Neue Verwendung eines Extraktes aus den Blättern von Ginkgo biloba |
JP3468526B2 (ja) * | 1995-10-26 | 2003-11-17 | サノフィーサンテラボ | 筋萎縮性側索硬化症治療薬調製のための1−(2−ナフタ−2−イルエチル)−4−(3−トリフルオロメチルフェニル)−1,2,3,6−テトラヒドロピリジンの使用 |
-
1998
- 1998-08-07 FR FR9810187A patent/FR2782008B1/fr not_active Expired - Fee Related
-
1999
- 1999-08-06 ES ES99936702T patent/ES2230873T3/es not_active Expired - Lifetime
- 1999-08-06 PT PT99936702T patent/PT1102586E/pt unknown
- 1999-08-06 WO PCT/FR1999/001948 patent/WO2000007592A1/fr active IP Right Grant
- 1999-08-06 AU AU51704/99A patent/AU5170499A/en not_active Abandoned
- 1999-08-06 CA CA002340021A patent/CA2340021C/fr not_active Expired - Fee Related
- 1999-08-06 DE DE69921662T patent/DE69921662T2/de not_active Expired - Lifetime
- 1999-08-06 JP JP2000563277A patent/JP4510289B2/ja not_active Expired - Fee Related
- 1999-08-06 AT AT99936702T patent/ATE281162T1/de active
- 1999-08-06 US US09/744,464 patent/US6524629B1/en not_active Expired - Lifetime
- 1999-08-06 EP EP99936702A patent/EP1102586B1/fr not_active Expired - Lifetime
-
2001
- 2001-02-06 NO NO20010627A patent/NO327733B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US6524629B1 (en) | 2003-02-25 |
DE69921662T2 (de) | 2005-10-20 |
CA2340021A1 (fr) | 2000-02-17 |
EP1102586B1 (fr) | 2004-11-03 |
FR2782008B1 (fr) | 2003-04-25 |
NO327733B1 (no) | 2009-09-14 |
ATE281162T1 (de) | 2004-11-15 |
JP4510289B2 (ja) | 2010-07-21 |
NO20010627L (no) | 2001-02-06 |
JP2002522387A (ja) | 2002-07-23 |
EP1102586A1 (fr) | 2001-05-30 |
DE69921662D1 (de) | 2004-12-09 |
ES2230873T3 (es) | 2005-05-01 |
FR2782008A1 (fr) | 2000-02-11 |
CA2340021C (fr) | 2009-09-15 |
AU5170499A (en) | 2000-02-28 |
PT1102586E (pt) | 2005-02-28 |
WO2000007592A1 (fr) | 2000-02-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20010627L (no) | Anvendelse av Gingko Biloba ekstrakter for fremstilling av et medikament for behandling av amyotrofisk lateral sclerose | |
WO1994027589A3 (en) | Antidepressant dosage form | |
MY127980A (en) | A pyrrolidineacetamide derivative alone or in combination for treatment of cns disorders | |
AU6158001A (en) | Drug/drug delivery systems for the prevention and treatment of vascular disease | |
ATE205086T1 (de) | Verwendung von dem chelatbildner clioquinol zur herstellung eines arzneimittelszur behandlung von alzheimerschen krankheit | |
WO2002056912A3 (en) | Pharmaceutical combination for the treatment of cancer containing a 4-quinazolineamine and another anti-neoplastic agent | |
ZA200300434B (en) | Medicinal herbal compounds for the prevention and treatment of diabetes. | |
HK1059215A1 (en) | Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome | |
HK1069327A1 (en) | Use of ginkgo biloba extracts for preparing a medicine for treating sarcopenia | |
WO2001030335A3 (en) | Pharmaceutical compositions useful in the prevention and treatment of beta-amyloid protein-induced disease | |
HK1068106A1 (en) | Use of sarp-1 for the treatment and/or prevention of scleroderma | |
EE9900162A (et) | Rinnavähi vältimise meetod, farmatseutiline preparaat ja toode ning toimeaine kasutamine | |
DE60002226D1 (de) | Zusammensetzung zur vorbeugung und/oder behandlung von kreislaufstörungen, enthaltend l-carnitin derivate und ginkgo biloba extrakte | |
DE69918961D1 (de) | Verbesserte inhalationspräparate | |
HUP9802897A3 (en) | Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient | |
EP0744176A3 (en) | Methods for inhibiting bone loss | |
WO2003018535A3 (en) | Novel aminobenzoephenones | |
DE69823226D1 (de) | Pharmazeutische zusammmensetzung, enthaltend ticlopidin und ginkgo biloba extrakt | |
PL374841A1 (en) | Use of ginkgo biloba extracts in order to promote muscle mass to the detriment of fatty mass | |
DE69918339D1 (de) | Pharmazeutische zusammensetzungen die selegilin und ginkgo biloba extrakt enthalten zur behandlung von demenz | |
HUP9902469A3 (en) | Use of ginkgo biloba extracts for the preparation of pharmaceutical compositions, and method of cosmetic treatment using a ginkgo biloba extract | |
HU9802896D0 (en) | Optically active piperidinoalkyl-4h-1,2,4-oxadiazine derivative, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient | |
HU206985B (en) | Process for producing vitalizing composition comprising gingko biloba extracts as main medicinal herb active ingredient | |
IT1304852B1 (it) | Miscela di piante medicinali per la prevenzione e la cura delleemorroidi. | |
SI1313489T1 (en) | Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |